Members of the Case Western Reserve University community are invited to a CWRU Entrepreneurship Speaker Series for a roundtable discussion with Timothy Miller (GRS ’08, pharmacology), co-founder and president at Forge Biologics. Miller will present “Turning Innovation Into Acquisition: A Biotech Entrepreneur’s Guide” Friday, Aug. 23, from 1 to 1:45 p.m. in the sixth-floor conference room in Sears think[box].
Forge Biologics Inc. is a VC-backed gene therapy development engine focused on accelerating access to potentially life-saving AAV gene therapies.
Miller also is founding CEO and president of Abeona Therapeutics, a rare disease NASDAQ gene/cell therapy company.
Miller is a proven biotech leader with experience in driving gene therapy pipeline development, regulatory strategy, investor relations, M&A activities, in-licensing, GMP manufacturing, clinical development and leading stakeholder/shareholder engagement. He has more than 20 years of business development, scientific research, product development and clinical operations expertise, with a focus on transitioning novel gene and cell therapies through pre-clinical – Phase 3 human clinical trials. He is an avid patient-centric drug developer and entrepreneur.